95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-6.85%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.30%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
4.90%
Positive net income growth while AEM is negative. John Neff might see a big relative performance advantage.
6.06%
Positive EPS growth while AEM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
6.06%
Positive diluted EPS growth while AEM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.09%
Share reduction more than 1.5x AEM's 0.21%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-0.31%
Reduced diluted shares while AEM is at 0.10%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
25.60%
Dividend growth under 50% of AEM's 79.94%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
-8.83%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-8.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
50.22%
Similar 10Y revenue/share CAGR to AEM's 47.21%. Walter Schloss might see both firms benefiting from the same long-term demand.
27.97%
5Y revenue/share CAGR under 50% of AEM's 72.37%. Michael Burry would suspect a significant competitive gap or product weakness.
16.22%
3Y revenue/share CAGR under 50% of AEM's 57.03%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
30.94%
10Y OCF/share CAGR under 50% of AEM's 210.10%. Michael Burry would worry about a persistent underperformance in cash creation.
39.76%
Below 50% of AEM's 157.04%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
24.07%
3Y OCF/share CAGR under 50% of AEM's 131.10%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
0.37%
Below 50% of AEM's 62.39%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
183.27%
Below 50% of AEM's 1284.20%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
212.45%
Below 50% of AEM's 459.00%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
98.34%
10Y equity/share CAGR above 1.5x AEM's 7.93%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
23.42%
5Y equity/share CAGR is in line with AEM's 23.05%. Walter Schloss would see parallel mid-term profitability and retention policies.
14.87%
3Y equity/share CAGR above 1.5x AEM's 9.83%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
139.09%
Below 50% of AEM's 331.16%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
39.29%
Below 50% of AEM's 238.63%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
-3.56%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
238799900.00%
We show growth while AEM is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-2.20%
Negative asset growth while AEM invests at 4.49%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.85%
75-90% of AEM's 3.41%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-59.56%
We’re deleveraging while AEM stands at 0.20%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-55.96%
We cut SG&A while AEM invests at 28.97%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.